To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
Clinical trial NCT05925452 · RECRUITING
Trial details
- NCT number
- NCT05925452
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2028-03-24
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.